Future studies are required in resource-limited set-ups like ours to assess the suitability of POCT testing in clinical settings (e.g., emergency department for strategies to rule in or rule out acute myocardial infarction (AMI)) and cost-effectiveness of standardizing the cTnI cutoffs between POCT and central laboratory assays. Here, TNNI3 is linked to acute myocardial infarction.